Close

Presentation

This content is available for: Workshop Reg Pass. Upgrade Registration
Optimized Patient-Specific Catheter Placement for Convection-Enhanced Nanoparticle Delivery in Recurrent Glioblastoma
DescriptionIntroduction: Glioblastoma multiforme (GBM) is the most common and deadliest of all primary brain cancers. One promising treatment strategy for patients with recurrent GBM is convection-enhanced delivery (CED) of Rhenium-186 (186Re)-nanoliposomes (RNL) to provide delivery of large, localized doses of radiation. The success of treatment by CED relies on proper catheter placement for therapy delivery to maximize tumor coverage and minimize the leakage to healthy tissue. In this project, we are developing an image-guided physics-based model to optimize catheter placement for RNL delivery on a patient-specific basis.

Methods: The mathematical model consists of 1) the steady-state flow field generated via the catheter infusion and the Darcy flow through the 3D brain domain, 2) the transport of RNL governed by an advection-diffusion equation, and 3) the point-spread function to transform the RNL distribution into the SPECT signal. Pre-delivery MRIs were used to assign patient-specific tissue geometries. Two scenarios were performed to personalize the model parameters: a) patient-specific calibration with longitudinal SPECT images monitoring RNL distributions, and b) population-based assignment with the leave-one-out cross-validation (LOOCV). The accuracy of model predictions was evaluated by the concordance correlation coefficients (CCC) between predicted and measured voxel-wise SPECT signals. Furthermore, in each patient, we used the image-guided model—with either calibrated or assigned parameters—to simulate RNL distributions for all possible locations of catheter tip(s), resulting in a ratio of the cumulative dose of RNL outside the tumor to that within the tumor, termed as “off-target ratio” (OTR). We minimized the OTR to optimize the placement of catheter(s), and compared OTRs obtained by the optimized and the original placements.

Results: Fifteen patients with recurrent GBM from a Phase I/II clinical trial of RNL were included in the study. For scenario a) with the patient-specific calibrated parameters, our model achieved median CCCs of 0.91, 0.87, and 0.82 for predicting RNL distributions at the mid-delivery, end-of-delivery, and 24 h post-delivery, respectively. For scenario b) with the LOOCV assigned parameters, our model achieved median CCCs of 0.89, 0.84, and 0.79 for predicting RNL distributions at the mid-delivery, end-of-delivery, and 24 h post-delivery, respectively. Compared to the original catheter placements, the optimized placements with the patient-specifically calibrated model achieved a median (range) of 34.56% (14.70% – 61.12%) reduction on OTR at the 24h post-delivery. Similarly, the optimized placements with the LOOCV assigned model achieved a 34.56% (13.30% – 56.62%) reduction on OTR at the 24h post-delivery. Furthermore, the optimization provides insights into whether a patient is a proper candidate for CED of RNL, and whether a reduction of catheter number is possible for the patient.

Conclusion: Our image-guided model, with either patient-specific calibrated parameters or LOOCV assigned parameters, achieved high accuracy for predicting RNL distributions up to 24 h after the RNL delivery. The placement of catheter(s) optimized via our modeling substantially reduced the off-target ratio of RNL delivery. These results proved the potential of our image-guided modeling to guide patient-specific optimization of catheter placement for convection-enhanced delivery of radiolabeled liposomes.

Acknowledgments: NCI R01CA235800, U01CA253540, and R01CA260003. CPRIT RR160005.
Event Type
Workshop
TimeSunday, 12 November 20234:15pm - 4:30pm MST
Location506
Tags
Applications
State of the Practice
Registration Categories
W